TELO Earnings — Telomir Pharmaceuticals, Inc. Common Stock Post-ER Performance | BigEarnings
TELO — Telomir Pharmaceuticals, Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$1.30
Market Cap$89.4M
P/E—
52W Range$1.05 – $3.10
Next Earnings2026-08-13
About Telomir Pharmaceuticals, Inc. Common Stock
Telomir Pharmaceuticals Inc is a preclinical-stage biotechnology company focused on the development of small-molecule therapeutics designed to address upstream biological drivers of aging and age-related diseases rather than treating symptoms alone. The company's research targets fundamental cellular processes associated with disease progression and functional decline, including metal-ion dysregulation, oxidative stress, epigenetic regulation, mitochondrial dysfunction, and telomere integrity. Telomir's investigational compound, Telomir-1 (Zn-Telomir), is a novel orally administered small molecule engineered to modulate intracellular metal balance particularly iron, copper, calcium, and zinc.
